Back to CORT overview

CORT Corcept Therapeutics PE ratio, current and historical analysis

As at Jun 14, 2024, the CORT stock has a price-to-earnings ratio of 25.19. This is based on the current EPS of $1.15 and the stock price of $28.97 per share. A decrease of 8% has been recorded in the PE ratio compared to the average of 27.4 of the past four quarters.

CORT PE ratio history

How has CORT's PE ratio performed in the past

The mean historical PE ratio of Corcept Therapeutics over the last eight years is 49.0. The current 25.19 price-to-earnings ratio is 49% less than the historical average. In the past eight years, CORT's PE ratio reached its highest point in the Jun 2016 quarter at 546, with a price of $5.46 and an EPS of $0.01. The Sep 2018 quarter saw the lowest point at 10.54, with a price of $14.02 and an EPS of $1.33.

Average
49
Median
22.33
Minimum
10.54
Maximum
546

Corcept Therapeutics PE ratio by year

Maximum annual increase: 92.62% in 2020

Maximum annual decrease: -84.73% in 2017

Year PE ratio Change
2023 31.84 48.92%
2022 21.38 4.75%
2021 20.41 -28.21%
2020 28.43 92.62%
2019 14.76 -28.18%
2018 20.55 29.73%
2017 15.84 -84.73%
2016 103.71 N/A
2015 N/A N/A
2014 N/A N/A

CORT average PE ratio chart

What is the average PE ratio of CORT for the past years

The current PE ratio of CORT is above its 3 and 5-year historical averages, but it is lower than the 10-year average.

3-year avg
24.48
5-year avg
22.39
10-year avg
49
15-year avg
49

CORT PE vs peers

What is CORT's PE ratio compared to its peers

When compared to its peers LLY and MRK, CORT's PE ratio is lower, but it is higher than JNJ's and NVS's.

Stock name PE ratio Market cap
JNJ Johnson & Johnson 9.54 $350.27B
NVS Novartis AG 14.27 $215.71B
CORT Corcept Therapeutics Inc 25.19 $3.02B
BMRN Biomarin Pharmaceutical Inc 76.61 $15.86B
MNKD Mannkind Corp 120 $1.31B
LLY ELI LILLY & Co 128.8 $834.88B
MRK Merck & Co Inc 142.29 $327.95B
BMY Bristol Myers Squibb Co N/A $83.52B
PFE Pfizer Inc N/A $156B
ESPR Esperion Therapeutics Inc N/A $566.49M

Frequently asked questions

What is Corcept Therapeutics's PE ratio?

The price to earnings ratio for CORT stock is 25.19 as of Jun 14, 2024.

What is the 3-year average PE ratio for Corcept Therapeutics (CORT)?

Over the last 3 years, the average PE ratio for CORT stock is 24.48.

What is the 5-year average PE ratio for Corcept Therapeutics (CORT)?

Over the last 5 years, the average PE ratio for CORT stock is 22.39.

What is the highest PE ratio for CORT?

In the last eight years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 546.

How does the current PE ratio for CORT compare to its historical average?

CORT's current price to earnings ratio is 49% below its 8-year historical average.

How is CORT's PE ratio calculated (Corcept Therapeutics PE ratio formula)?

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 14, 2024), Corcept Therapeutics's stock price is $28.97. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $1.15. Therefore, Corcept Therapeutics's price to earnings ratio for today is 25.19. PE RATIO(25.19) = STOCK PRICE($28.97) / TTM EPS($1.15)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.